Treves, Nir
Mor, Noa
Allegaert, Karel
Bassalov, Hely
Berkovitch, Matitiahu
Stolar, Orit E.
Matok, Ilan
Article History
Received: 2 August 2021
Accepted: 9 November 2021
First Online: 6 December 2021
Competing interests
: Prof. Berkovitch and Dr. Stolar report grants from Canndoc, outside the submitted work. Prof Karel Allegaert is a member of the data safety monitoring committee on a study that assesses the safety, tolerability, and pharmacokinetics, of GWP42003-P (cannabidiol) in conjunction with hypothermia in neonates with moderate or severe hypoxic ischemic encephalopathy (sponsor GW Research Ltd, beneficiary: KU Leuven, Belgium). The other authors have no example conflicts of interest to disclose.